Integrated Cytometry System standardizes testing procedures.
Press Release Summary:
Offering laboratory information system (LIS) connectivity, Integrated Cytometry Solution combines FC 500 flow cytometer with FP 1000 sample processing system to streamline workflow and provide complete patient sample tracking. Solution, suited for high-volume clinical reference laboratories, tracks samples throughout testing process, from receipt and preparation to acquisition and analysis of data to reporting of results.
Original Press Release:
Beckman Coulter Launches Integrated Cytometry Solution
New System Streamlines Workflow and Provides Complete Patient Sample Tracking FULLERTON, Calif., Sept. 13 / -- Beckman Coulter, Inc. (NYSE:BEC) has launched its new Integrated Cytometry Solution (ICS), which combines Beckman Coulter's FC 500 flow cytometer with the new FP 1000 sample processing system. The new solution, now shipping, is the first integrated system to offer laboratory information system (LIS) connectivity. "This new solution reflects the essence of our company's strategy -- to simplify and automate customer processes to improve productivity," said Bonnie Anderson, vice president of Beckman Coulter's Translational Solutions Business Center. "Through the introduction of a fully-integrated cytometry solution, we are further securing our position as a leader in flow cytometry automation." Ideally suited for high-volume clinical reference laboratories, ICS streamlines workflow and tracks samples throughout the testing process -- from receipt and preparation, to acquisition and analysis of data, to reporting results. This approach helps laboratories standardize their flow cytometry testing processes, resulting in an increase in efficiency, accuracy and operator safety. "The automation and integration advancements of our new Integrated Cytometry Solution will help reduce the cost of results reporting and speed critical information to caregivers," said Anderson. Flow cytometry is widely used to provide automated analysis of various blood cell populations. It is commonly used in in vitro diagnostics to identify and enumerate certain cell populations that are key indicators of diseases including HIV, leukemia and lymphoma. These indicators are instrumental in monitoring disease progression and effectiveness of therapy. Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum -- from pioneering medical research and clinical trials to laboratory diagnostics and point-of- care testing -- Beckman Coulter's 200,000 installed systems provide essential biomedical information to enhance health care around the world. The company, based in Fullerton, Calif., reported 2004 annual sales of $2.4 billion with 64 percent of this amount generated by recurring revenue from supplies, test kits and services. For more information, visit www.beckmancoulter.com.
